Chronological changes in MRI and CSF biochemical markers in Creutzfeldt-Jakob disease patients

被引:5
作者
Satoh, Katsuya
Shirabe, Susumu
Eguchi, Hiroto
Tsujino, Akira
Motomura, Masakatsu
Satoh, Akira
Tsujihata, Mitsuhiro
Eguchi, Katsumi
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Internal Med 1, Nagasaki 8528501, Japan
[2] Nagasaki Kita Hosp, Nagasaki, Japan
关键词
Creutzfeldt-Jakob disease; total tau protein; diffusion-weighted magnetic resonance imaging;
D O I
10.1159/000101339
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: There are currently no markers for evaluating chronological changes in Creutzfeldt-Jakob disease (CJD). We examined if chronological changes in biochemical markers in cerebrospinal fluid (CSF) and diffusion-weighted magnetic resonance imaging (DWI) were utilizable for this purpose. Methods: Ten independent patients were divided into two groups of 5 patients each. We analyzed CSF biochemical markers, DWI and the clinical course in one group. In the remaining group, only the CSF biochemical markers were analyzed before and after the onset of akinetic mutism. Results: The level of total tau (t-tau) protein in CSF in the early phase after disease onset was 2,655 +/- 423.9 pg/ml, reaching a mean peak of 14,675 +/- 1,240 pg/ml in the middle phase and gradually declining after that. Just before patients deteriorated into akinetic mutism, t-tau protein titers reached a maximum (8,786 +/- 2,975 pg/ml). There were dramatic changes in t-tau protein levels throughout the clinical course, unlike the other markers. DWI was not always utilizable, because of discordance with clinical symptoms seen in this study. Four cases exhibited peaks in t-tau protein levels while the patients fell into akinetic mutism except 1 case. Conclusion: Our results suggest that t-tau protein is the most sensitive marker of disease progression in CJD patients. Copyright (c) 2007 S. Karger AG, Basel.
引用
收藏
页码:372 / 381
页数:10
相关论文
共 14 条
[1]   Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease [J].
Aksamit, AJ ;
Preissner, CM ;
Homburger, HA .
NEUROLOGY, 2001, 57 (04) :728-730
[2]   14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease [J].
Beaudry, P ;
Cohen, P ;
Brandel, JP ;
Delasnerie-Lauprêtre, N ;
Richard, S ;
Launay, JM ;
Laplanche, JL .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (01) :40-46
[3]   Diagnosis of Creutzfeldt-Jakob disease -: Effect of clinical criteria on incidence estimates [J].
Brandel, JP ;
Delasnerie-Lauprêtre, N ;
Laplanche, JL ;
Hauw, JJ ;
Alpérovitch, A .
NEUROLOGY, 2000, 54 (05) :1095-1099
[4]   Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease [J].
Cepek, L ;
Steinacker, P ;
Mollenhauer, B ;
Wiese, B ;
Ciesielczyk, B ;
Bibl, M ;
Wiltfang, J ;
Zerr, I ;
Schulz-Schaeffer, W ;
Kretzschmar, HA ;
Poser, S ;
Otto, M .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 19 (5-6) :376-382
[5]   MRI of Creutzfeldt-Jakob disease: Imaging features and recommended MRI protocol [J].
Collie, DA ;
Sellar, RJ ;
Zeidler, M ;
Colchester, ACF ;
Knight, R ;
Will, RG .
CLINICAL RADIOLOGY, 2001, 56 (09) :726-739
[6]   Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease [J].
Kropp, S ;
Zerr, I ;
Schulz-Schaeffer, WJ ;
Riedemann, C ;
Bodemer, M ;
Laske, C ;
Kretzschmar, HA ;
Poser, S .
NEUROSCIENCE LETTERS, 1999, 261 (1-2) :124-126
[7]   Creutzfeldt-Jakob disease: Serial changes on diffusion-weighted MRI [J].
Matoba, M ;
Tonami, H ;
Miyaji, H ;
Yokota, H ;
Yamamoto, I .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2001, 25 (02) :274-277
[8]   Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease [J].
Otto, M ;
Wiltfang, J ;
Cepek, L ;
Neumann, M ;
Mollenhauer, B ;
Steinacker, P ;
Ciesielezyk, B ;
Schulz-Schaeffer, W ;
Kretzschmar, HA ;
Poser, S .
NEUROLOGY, 2002, 58 (02) :192-197
[9]   14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan [J].
Satoh, K ;
Shirabe, S ;
Eguchi, H ;
Tsujino, A ;
Eguchi, K ;
Satoh, A ;
Tsujihata, M ;
Niwa, M ;
Katamine, S ;
Kurihara, S ;
Matsuo, H .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2006, 26 (01) :45-52
[10]   Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease [J].
Shiga, Y ;
Miyazawa, K ;
Sato, S ;
Fukushima, R ;
Shibuya, S ;
Sato, Y ;
Konno, H ;
Doh-ura, K ;
Mugikura, S ;
Tamura, H ;
Higano, S ;
Takahashi, S ;
Itoyama, Y .
NEUROLOGY, 2004, 63 (03) :443-449